English  |  正體中文  |  简体中文  |  总笔数 :2853327  
造访人次 :  44999413    在线人数 :  1835
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"lu l c"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 1-25 / 144 (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-09-15T01:08:47Z Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites Guo J.-C.; Lin C.-Y.; Chia-Chi Lin; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H.
臺大學術典藏 2022-09-14T01:29:23Z Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; CHIEN-HUNG CHEN; Cheng A.-L.
臺大學術典藏 2022-08-23T02:35:03Z Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏 2022-08-19T06:48:44Z Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU
臺大學術典藏 2022-08-19T00:20:55Z Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems Shen Y.-C.; Hsu C.-H.; Cheng A.-L.; CHIUN HSU; Lin Z.-Z.; Lu L.-C.; Shao Y.-Y.
臺大學術典藏 2022-08-19T00:20:38Z Considerations of heterogeneity in clinical trials for hepatocellular carcinoma Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; CHIUN HSU; Lin Z.-Z.; Liu T.-H.; Shao Y.-Y.; Lu L.-C.
臺大學術典藏 2022-08-19T00:20:36Z Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma Shao Y.-Y.; Liu T.-H.; CHIUN HSU; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2022-08-19T00:20:26Z Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy CHIUN HSU; Shao Y.-Y.; Chen C.-H.; Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.-H.; Lin Z.-Z.; Lu L.-C.; Liu T.-H.; Cheng A.-L.
臺大學術典藏 2022-08-19T00:20:25Z Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma Liang P.-C.; Liu T.-H.; Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chen B.-B.; Shih T.T.-F.; Shen Y.-C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2022-06-10T06:11:07Z Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems Shao Y.-Y.; Lu L.-C.; ZHONG-ZHE LIN; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2022-06-10T06:11:06Z Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma Lu L.-C.; Shao Y.-Y.; Kuo R.N.C.; ZHONG-ZHE LIN; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2022-06-10T06:10:58Z Considerations of heterogeneity in clinical trials for hepatocellular carcinoma Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; ZHONG-ZHE LIN; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2022-06-10T06:10:56Z Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma Shao Y.-Y.; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; ZHONG-ZHE LIN; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2022-06-10T06:10:52Z Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; ZHONG-ZHE LIN; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L.
臺大學術典藏 2022-04-25T07:36:11Z Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; JIA-HAU LIU; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏 2022-04-14T07:20:22Z Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; FENG-MING TIEN; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏 2022-04-07T01:43:07Z Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; TSUNG-HAO LIU; Chen C.-H.; Cheng A.-L.
臺大學術典藏 2022-03-31T02:39:22Z Targeted Disruption in Mice of a Neural Stem Cell-Maintaining, KRAB-Zn Finger-Encoding Gene That Has Rapidly Evolved in the Human Lineage Chien H.-C.; Wang H.-Y.; Su Y.-N.; Lai K.-Y.; Lu L.-C.; PAU-CHUNG CHEN; Tsai S.-F.; Wu C.-I.; Hsieh W.-S.; Shen C.-K.J.
臺大學術典藏 2022-03-30T08:21:31Z Molecular epidemiology of japanese encephalitis virus, Taiwan Huang J.-H.; Lin T.-H.; Teng H.-J.; Su C.-L.; KUN-HSIEN TSAI; Lu L.-C.; Lin C.; Yang C.-F.; Chang S.-F.; Liao T.-L.; Yu S.-K.; Cheng C.-H.; Chang M.-C.; Hu H.-C.; Shu P.-Y.
臺大學術典藏 2022-03-30T08:21:27Z Molecular Epidemiology of Japanese Encephalitis Virus in Mosquitoes in Taiwan during 2005–2012 Su C.-L.; Yang C.-F.; Teng H.-J.; Lu L.-C.; Lin C.; KUN-HSIEN TSAI; Chen Y.-Y.; Chen L.-Y.; Chang S.-F.; Shu P.-Y.
臺大學術典藏 2022-03-22T08:30:38Z Wafer-scale nanocracks enable single-molecule detection and on-site analysis Chang Y.-L;Lai I.-C;Lu L.-C;Chang S.-W;Sun A.Y;Wan D;Chen H.-L.; Chang Y.-L; Lai I.-C; Lu L.-C; Chang S.-W; Sun A.Y; Wan D; Chen H.-L.; HSUEN-LI CHEN
臺大學術典藏 2022-03-22T08:30:37Z Wafer-scale nanocracks enable single-molecule detection and on-site analysis Chang Y.-L;Lai I.-C;Lu L.-C;Chang S.-W;Sun A.Y;Wan D;Chen H.-L.; Chang Y.-L; Lai I.-C; Lu L.-C; Chang S.-W; Sun A.Y; Wan D; Chen H.-L.; HSUEN-LI CHEN
臺大學術典藏 2022-03-22T08:27:38Z Wafer-scale nanocracks enable single-molecule detection and on-site analysis Chang Y.-L;Lai I.-C;Lu L.-C;Chang S.-W;Sun A.Y;Wan D;Chen H.-L.; Chang Y.-L; Lai I.-C; Lu L.-C; Chang S.-W; Sun A.Y; Wan D; Chen H.-L.; HSUEN-LI CHEN
臺大學術典藏 2022-03-15T03:29:02Z Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites Guo J.-C.; Lin C.-Y.; Lin C.-C.; TA-CHEN HUANG; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H.
臺大學術典藏 2022-03-08T03:44:01Z Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma SHIH-HUNG YANG; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H.

显示项目 1-25 / 144 (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目